Dr. Beninger joins Tufts CTSI as Associate Director of Regulatory Affairs. He is Associate Professor of Public Health & Community Medicine at Tufts University School of Medicine, where he is the Director of the MD/MBA and MBS/MBA Programs. He has more than three decades of experience as a regulator and member of the Senior Executive Service in the US Food and Drug Administration, as a manager and executive in the pharmaceutical industry and as a member of the academic community.
Dr. Beninger trained in internal medicine and infectious diseases. He received his MD from the University of California, Davis, his BA from Claremont McKenna College in Claremont, California, his MBA from St Joseph’s University in Philadelphia, Pennsylvania, and his graduate certificate in epidemiology from Tufts. He has published and spoken extensively on regulatory science, drug and vaccine safety, and pharmacovigilance.
The Tufts CTSI Regulatory Affairs team facilitates the improvement of clinical trials processes and the responsible conduct of human subjects research through interaction with local, state, and federal agencies and Tufts CTSI-affiliated organizations.
Starting September 2022, Dr. Beninger joins Director of Regulatory Affairs, Andreas Klein, MD; Director of Data Safety and Monitoring Boards, Ludovic Trinquart, PhD; and Research Participant Advocate, Patricia Normandin, DNP.
To request a consultation, please use the service request form (select General Consult and use the text box to describe your Regulatory question or request).